Cellosaurus logo
expasy logo

Cellosaurus UACC-2534 (CVCL_M452)

[Text version]
Cell line name UACC-2534
Synonyms UACC 2534; UACC2534; University of Arizona Cell Culture-2534
Accession CVCL_M452
Resource Identification Initiative To cite this cell line use: UACC-2534 (RRID:CVCL_M452)
Comments Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 68Y
Category Cancer cell line
Publications

PubMed=10952317; DOI=10.1038/35020115
Bittner M., Meltzer P.S., Chen Y.-D., Jiang Y., Seftor E.A., Hendrix M.J.C., Radmacher M.D., Simon R.M., Yakhini Z., Ben-Dor A., Sampas N., Dougherty E., Wang E., Marincola F.M., Gooden G.C., Lueders J., Glatfelter A., Pollock P.M., Carpten J.D., Gillanders E.M., Leja D., Dietrich K., Beaudry C., Berens M.E., Alberts D.S., Sondak V.K., Hayward N.K., Trent J.M.
Molecular classification of cutaneous malignant melanoma by gene expression profiling.
Nature 406:536-540(2000)

PubMed=23039341; DOI=10.1186/1476-4598-11-75; PMCID=PMC3554420
Byron S.A., Loch D.C., Wellens C.L., Wortmann A., Wu J.-Y., Wang J., Nomoto K., Pollock P.M.
Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status.
Mol. Cancer 11:75.1-75.15(2012)

PubMed=24879157; DOI=10.4161/auto.28594; PMCID=PMC4091172
Goodall M.L., Wang T., Martin K.R., Kortus M.G., Kauffman A.L., Trent J.M., Gately S., MacKeigan J.P.
Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib.
Autophagy 10:1120-1136(2014)

Cross-references
Anatomy/cell type resources BTO; BTO:0005897
Encyclopedic resources Wikidata; Q54973822
Polymorphism and mutation databases Cosmic; 1211155
Entry history
Entry creation05-Nov-2013
Last entry update29-Jun-2023
Version number10